{"id":"W3211864651","doi":"10.1182/blood-2021-151711","title":"Long-Term Outcome of Treatment-Naïve and Relapsed/Refractory Patients with CLL and <i>TP53</i> Aberrations Treated with Ibrutinib, with or without Rituximab","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Medicine; Rituximab; Internal medicine; Neutropenia; Progression-free survival; Oncology; Chronic lymphocytic leukemia; Lymphocytosis; Refractory (planetary science); Median follow-up; Leukemia; Chemotherapy; Lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004547208,0.000207767,0.0006085206,0.000201525,0.000375683,0.0005572272,0.0002541421,0.0005189567,0.0009652799],"category_scores_gemma":[0.0006821485,0.0001262844,0.0005541288,0.0002594886,0.000270723,0.0004414065,0.0002324283,0.0005546195,0.0002789209],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005490101,"about_ca_system_score_gemma":0.0002536101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001239935,"about_ca_topic_score_gemma":0.00128096,"domain_scores_codex":[0.9998036,0.00005417837,0.00001837928,0.00004604201,0.00002697198,0.0000508882],"domain_scores_gemma":[0.9993136,0.0001297861,0.0002206857,0.00003867053,0.00005475326,0.0002424568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04057483,0.001854622,0.9150753,0.0001207526,0.0007844087,0.00124997,0.0002526736,0.001285272,0.008394331,0.00006234167,0.001287542,0.02905795],"study_design_scores_gemma":[0.002094073,0.01870493,0.9733107,0.00003454127,0.0005475031,0.001550646,0.000153835,0.001119943,0.001149672,0.00008145835,0.001221729,0.00003088083],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987972,0.0005318919,0.00003558696,0.00003855721,0.000008835101,0.00001303852,0.0002794986,0.000002530167,0.0002928827],"genre_scores_gemma":[0.998558,0.0001471475,0.00002649884,0.00007395444,0.0000282076,0.00002088867,0.0009168972,0.000001131409,0.0002273105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001239935,"threshold_uncertainty_score":0.003983319,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02149044637896687,"score_gpt":0.2866232311997149,"score_spread":0.265132784820748,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}